Results 261 to 270 of about 76,496 (274)

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Lancet Infectious Diseases, The, 2014
Ali S Omrani, Kamran Baig, Ziad Ahmed Memish   +2 more
exaly  

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Gut, 2016
Kerstin Herzer, Peter Ferenci, Michael Gschwantler   +2 more
exaly  

Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA

Proceedings of the National Academy of Sciences of the United States of America, 2018
François Ferron, Lorenzo Subissi, Etienne Decroly   +2 more
exaly  

Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)

Hepatology, 2016
Peter Angus, Gregory J Dore, Stanislas Pol   +2 more
exaly  

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

Gut, 2016
Daniel Todt, Andreas Nitsche, Patrick Behrendt   +2 more
exaly  

Ribavirin for HIV

The Lancet, 1991
openaire   +2 more sources

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Nature Genetics, 2009
Yasuhito Tanaka, Naoya Sakamoto, Keisuke Hino   +2 more
exaly  

Ribavirine et ventilation mécanique

Archives de Pédiatrie, 1996
openaire   +4 more sources

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Lancet, The, 2015
Chloe Orkin, Mark Nelson, Christoph J Stephan   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly